Timothy J. Barberich

Timothy J. Barberich, listed as board member, appears in our data through filings on TScan Therapeutics, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 20 July 2021 and the latest from 18 December 2023.

Every open-market trade on record is a purchase: 2 purchases worth €222k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2023, the count stands at 2 purchases and no sales.

The record was last updated on 21 December 2023 with an open-market purchase (€129k) in TScan Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.